Caocci, G., Mulas, O., Mantovani, D., Costa, A., Galizia, A., Barabino, L., . . . La Nasa, G. (2021). Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis. Ann Hematol.

Caocci, Giovanni, Olga Mulas, Daniela Mantovani, Alessandro Costa, Andrea Galizia, Luca Barabino, Marianna Greco, Roberta Murru, and Giorgio La Nasa. "Ruxolitinib Does Not Impair Humoral Immune Response to COVID-19 Vaccination With BNT162b2 MRNA COVID-19 Vaccine in Patients With Myelofibrosis." Ann Hematol 2021.

Caocci, Giovanni, et al. "Ruxolitinib Does Not Impair Humoral Immune Response to COVID-19 Vaccination With BNT162b2 MRNA COVID-19 Vaccine in Patients With Myelofibrosis." Ann Hematol 2021.